The rise of oculomics and prospects for its clinical application
DOI:
Author:
Corresponding Author:

Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    The eye serves as a window to systemic health. With rapid advances in fundus imaging and artificial intelligence (AI) technologies, oculomics has emerged in recent years. Omics is a field that studies the composition, interactions, and dynamic changes of various molecules within living body at a holistic level. Oculomics refers to the discipline that integrates macroscopic, microscopic, and molecular-level characteristics of the eye associated with health and diseases, particularly by combining multimodal retinal imaging data to identify ocular biomarkers specific to systemic diseases. The goal of oculomics is to develop rapid, non-invasive, and cost-effective biomarkers for screening and diagnosing systemic diseases, as well as for risk stratification and prioritizing treatment. The integration of big data, AI, and oculomics helps ensure that these biomarkers are sufficiently reliable and reproducible for increasing application in various clinical scenarios including cardiovascular diseases, neurological and mental disorders, respiratory diseases, blood diseases, immune and infectious diseases.

    Reference
    Related
    Cited by
Get Citation
Article Metrics
  • Abstract:
  • PDF:
Publication History
  • Received:September 08,2026
  • Revised:September 19,2026
  • Adopted:September 21,2026
  • Online: November 11,2026
  • Published: